Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Long-Term Debt Repayments (2020 - 2025)

Maravai Lifesciences Holdings has reported Long-Term Debt Repayments over the past 6 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Long-Term Debt Repayments at $1.4 million for Q4 2025, down 99.41% from a year ago — trailing twelve months through Dec 2025 was $5.4 million (down 97.68% YoY), and the annual figure for FY2025 was $5.4 million, down 97.68%.
  • Long-Term Debt Repayments for Q4 2025 was $1.4 million at Maravai Lifesciences Holdings, roughly flat from $1.4 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for MRVI hit a ceiling of $230.3 million in Q4 2024 and a floor of $1.2 million in Q2 2021.
  • Median Long-Term Debt Repayments over the past 5 years was $1.4 million (2022), compared with a mean of $13.2 million.
  • Biggest five-year swings in Long-Term Debt Repayments: skyrocketed 16834.78% in 2024 and later crashed 99.41% in 2025.
  • Maravai Lifesciences Holdings' Long-Term Debt Repayments stood at $1.5 million in 2021, then dropped by 9.33% to $1.4 million in 2022, then changed by 0.0% to $1.4 million in 2023, then skyrocketed by 16834.78% to $230.3 million in 2024, then crashed by 99.41% to $1.4 million in 2025.
  • The last three reported values for Long-Term Debt Repayments were $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.